A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/19/2009	WO2009138779A1 Combination comprising 4- (3-chloro-2-fluoroanilino) -7-meth0xy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxyjquinazoline
11/19/2009	WO2009138761A1 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections
11/19/2009	WO2009138758A2 Bis-aryl compounds for use as medicaments
11/19/2009	WO2009138737A1 Topical composition of opioid compound for use in wound healing
11/19/2009	WO2009138734A2 Use of opioid compounds in peripheral pain, wound healing and scar formation
11/19/2009	WO2009138707A1 Quinuclidine derivatives as muscarinic m3 receptor antagonists
11/19/2009	WO2009138533A1 Set of antiangiogenic molecules and use thereof
11/19/2009	WO2009138517A1 Emollient composition
11/19/2009	WO2009138516A1 Therapy regimen for treating acne related diseases
11/19/2009	WO2009138515A1 Emollient composition for the preventive treatment of atopic dermatitis
11/19/2009	WO2009138509A1 Multiple myeloma treatments
11/19/2009	WO2009138487A1 Pharmaceutical compositions for the treatment of warts
11/19/2009	WO2009138440A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
11/19/2009	WO2009138438A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
11/19/2009	WO2009138437A1 Salicylate conjugates useful for treating metabolic disorders
11/19/2009	WO2009138416A1 Oxime carbamoyl derivatives as modulators of fatty acid amides hydrolase
11/19/2009	WO2009138393A1 5-[5-[2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoylmethylamino]-4-(4-fluoro-2-methylphenyl)]-2-pyridinyl-2-alkyl-prolinamide as nk1 receptor antagonists
11/19/2009	WO2009138378A1 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases
11/19/2009	WO2009138376A1 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
11/19/2009	WO2009138340A1 Inhibitors of jnk
11/19/2009	WO2009138338A1 Novel n-(2-amino-phenyl)-acrylamides
11/19/2009	WO2009138224A1 Pharmaceutical composition comprising drospirenone
11/19/2009	WO2009138198A2 Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders
11/19/2009	WO2009138195A2 Use of thiophene glycoside derivatives for producing medicaments for treatment of hypertension
11/19/2009	WO2009138176A1 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines as gsk3beta-inhibitors
11/19/2009	WO2009138170A2 Film-shaped preparation comprising oily substances for oral administration
11/19/2009	WO2009138165A1 Sgc stimulators, sgc activators and combinations thereof for the treatment of hearing impairment
11/19/2009	WO2009138122A1 Purine derivatives further comprising a mercapto-acylamino group as neutral endopeptidase inhibitors
11/19/2009	WO2009138094A1 Pharmaceutical compositions
11/19/2009	WO2009137966A1 A inhibitor for depressing the absorption of sucrose
11/19/2009	WO2009137916A1 Processes and intermediates for the preparation of oseltamivir and analogs thereof
11/19/2009	WO2009137912A1 Oligonucleotides for treating inflammation and neoplastic cell proliferation
11/19/2009	WO2009137900A2 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
11/19/2009	WO2009137899A2 Sulfated galactans with antithrombotic activity, pharmaceutical composition, method for treating or prophylaxis of arterial or venous thrombosis, method of extraction and use thereof
11/19/2009	WO2009137871A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	WO2009137859A1 Compounds for the treatment of metabolic syndrome and insulin resistance
11/19/2009	WO2009123457A3 Ubiquitin alone or in combination for use in the treatment of sweet itch
11/19/2009	WO2009121039A3 Administration of benzodiazepine compositions
11/19/2009	WO2009118475A3 Platinum-n-heterocyclic carbene derivatives, preparation thereof and therapeutic use thereof
11/19/2009	WO2009118473A3 Azetidine-derived compounds, preparation method therefor and therapeutic use of same
11/19/2009	WO2009114856A3 Aurora kinase inhibitors
11/19/2009	WO2009114763A3 Enzymatic substrates for multiple detection systems
11/19/2009	WO2009114368A3 Activated nitric oxide donors and methods of making and using thereof
11/19/2009	WO2009112550A4 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds
11/19/2009	WO2009108005A3 Composition and method for screening active material used for the prevention and treatment of diabetes or obesity using senp2 and composition for the prevention and treatment of diabetes or obesity
11/19/2009	WO2009105238A3 Kinase protein binding inhibitors
11/19/2009	WO2009105230A3 Methods for treating cancer using combination therapy
11/19/2009	WO2009105218A3 Propiophenone derivatives
11/19/2009	WO2009105165A3 Cardioplegia solution for cardiac surgery
11/19/2009	WO2009104939A3 Pharmaceutical preparation
11/19/2009	WO2009104054A3 Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration
11/19/2009	WO2009103427A3 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation
11/19/2009	WO2009103007A3 Steroid hormone receptor modulator compounds and methods
11/19/2009	WO2009102880A3 Structure and bioactivity of the polysaccharides and oligomers in medicinal plant dendrobium huoshanense
11/19/2009	WO2009100723A3 Crystalline forms of an antibiotic substance
11/19/2009	WO2009100422A3 Drug delivery system comprising microparticles and gelation system
11/19/2009	WO2009100406A3 Topical formulations for the treatment of psoriasis
11/19/2009	WO2009099716A4 Novel vaccines against multiple subtypes of dengue virus
11/19/2009	WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition
11/19/2009	WO2009097228A4 Composition and method for treating and preventing musculoskeletal and connective tissue disorders
11/19/2009	WO2009093242A3 Cell populations for polypeptide analysis and uses of same
11/19/2009	WO2009089537A3 Anti-cancer compounds
11/19/2009	WO2009088192A9 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
11/19/2009	WO2009087658A3 Ketorolac tromethamine containing parenteral formulation
11/19/2009	WO2009074300A8 Hedgehog pathway antagonists and therapeutic applications thereof
11/19/2009	WO2009063491A3 Topical compositions for skincare
11/19/2009	WO2009051824A3 Combination analgesic employing opioid and neutral antagonist
11/19/2009	WO2009040659A3 Benzenesulfonamide compounds and the use thereof
11/19/2009	WO2009036082A3 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use
11/19/2009	WO2009034431A3 Controlled-release dosage forms for varenicline
11/19/2009	WO2009015447A3 Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders
11/19/2009	WO2009007411A3 Inhibition of age formation
11/19/2009	WO2008145839A8 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
11/19/2009	WO2008131940A3 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/19/2009	WO2008128049A3 Tetrahydrobiopterin compositions and methods of measuring
11/19/2009	WO2008109437A3 Compositions comprising derivatives of 3 -phenylpyridazine for treating seizure-related disorders
11/19/2009	WO2007146953A8 Compositions and methods for sirna inhibition of angiogenesis
11/19/2009	US20090286987 Metalloprotein inhibitors
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286983 Pyrazolopyridine Derivates
11/19/2009	US20090286969 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
11/19/2009	US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009	US20090286884 Hops Beta-Acid Anti-Diabetic Composition
11/19/2009	US20090286883 Treatment of heart failure and associated conditions by administration of monoamine oxidase inhibitors
11/19/2009	US20090286882 Cyclopropylacetic Acid Derivatives and Use Thereof
11/19/2009	US20090286881 Selected betaines and their uses
11/19/2009	US20090286880 Novel process
11/19/2009	US20090286879 Preventive or Therapeutic Drug for Alzheimer-Type Dementia
11/19/2009	US20090286876 Neuroprotective benzoate and benzamide compounds
11/19/2009	US20090286875 Isocystene derivatives for the treatment of pain
11/19/2009	US20090286874 Anti-aging composition containing phloretin
11/19/2009	US20090286873 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure
11/19/2009	US20090286872 Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties
11/19/2009	US20090286871 Use of a plant oil product as an agent for increasing the synthesis of skin lipids
11/19/2009	US20090286870 Cancer Treatment Using FTS and 2-Deoxyglucose
11/19/2009	US20090286869 Flavanols and B-Type Procyanidins and Inflammation
11/19/2009	US20090286868 2-Amino-2-oxoethyl trans-3-[5-(naphth-1-yl)-1,3-dioxan-2-yl]propyl carbamate; reacting the phenylcarbonate with 2-aminodioxane; fatty acid amido hydrolase (FAAH) inhibitors; analgesics; nervous system disorders; gastrointestinal disorders,; to name just a few
11/19/2009	US20090286867 Compositions and methods of administering doxepin to mucosal tissue
11/19/2009	US20090286866 Double compartment skincare products comprising avermectin/milbemycin compounds
11/19/2009	US20090286865 Potentiator of antitumoral agents in the treatment of cancer

1 ... 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 ... 7860